Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.627
Neutral
RSI(14)
47.463
Neutral
STOCH(KDJ)(9,3,3)
73.918
Neutral
ATR(14)
2.380
Low Volatility
CCI(14)
128.272
Buy
Williams %R
22.072
Buy
TRIX(12,20)
-0.856
Sell
StochRSI(14)
81.077
Buy
Hims & Hers Health Inc
HIMS39.200USD
-0.810-2.02%
Close 12/05, 16:00（ET）Quotes delayed by 15 min
8.92BMarket Cap
66.66P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Hims & Hers Health Inc
Currency: USD Updated: 2025-12-05Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Hims & Hers Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
14
analysts
Hold
Current Rating
46.601
Target Price
+18.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Hims & Hers Health Inc Highlights
StrengthsRisks
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 180.22% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 65.46, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 195.39M shares, decreasing 0.45% quarter-over-quarter.
Held by Paul Tudor Jones
Star Investor Paul Tudor Jones holds 387.49K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.72.
Financial Health
Currency: USD Updated: 2025-12-05The company's current financial score is 7.32, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 598.98M, representing a year-over-year increase of 49.16%, while its net profit experienced a year-over-year increase of 79.13%.
Score
Financials
8.83
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
5.55
Operational Efficiency
6.74
Growth Potential
8.22
Shareholder Returns
7.27
Hims & Hers Health Inc's Company Valuation
Currency: USD Updated: 2025-12-05The company’s current valuation score is 5.71, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 65.46, which is 320.12% below the recent high of 275.02 and 3325.71% above the recent low of -2111.58.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 40/78
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-05The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Providers & Services industry's average of 7.54. The average price target for Hims & Hers Health Inc is 41.00, with a high of 85.00 and a low of 30.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
14
analysts
Hold
Current Rating
46.601
Target Price
+18.88%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
64
Total
7
Median
9
Average
Company name
Ratings
Analysts
Hims & Hers Health Inc
HIMS
14
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-05The company’s current price momentum score is 9.18, which is higher than the Healthcare Providers & Services industry's average of 7.39. Sideways: Currently, the stock price is trading between the resistance level at 43.64 and the support level at 33.82, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
38.022
Buy
MA10
37.785
Buy
MA20
37.651
Buy
MA50
46.138
Sell
MA100
48.675
Sell
MA200
46.047
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-05The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.03. The latest institutional shareholding proportion is 89.11%, representing a quarter-over-quarter decrease of 3.53%. The largest institutional shareholder is The Vanguard, holding a total of 19.47M shares, representing 8.88% of shares outstanding, with 3.77% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Capital World Investors
Farallon Capital Management, L.L.C.
Dudum (Andrew)
Goldman Sachs & Company, Inc.
State Street Investment Management (US)
Morgan Stanley & Co. LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-12-05The company’s current risk assessment score is 4.29, which is lower than the Healthcare Providers & Services industry's average of 5.55. The company's beta value is 2.36. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
2.35
VaR
+7.04%
240-Day Maximum Drawdown
+63.12%
240-Day Volatility
+111.11%
Return
Best Daily Return
60 days
+16.18%
120 days
+16.18%
5 years
+31.02%
Worst Daily Return
60 days
-15.84%
120 days
-34.63%
5 years
-34.63%
Sharpe Ratio
60 days
-0.57
120 days
-0.25
5 years
+0.65
Risk Assessment
Maximum Drawdown
240 days
+63.12%
3 years
+63.12%
5 years
+81.03%
Return-to-Drawdown Ratio
240 days
+0.77
3 years
+2.18
5 years
+0.42
Skewness
240 days
-0.34
3 years
+0.30
5 years
+0.34
Volatility
Realised Volatility
240 days
+111.11%
5 years
+84.75%
Standardised True Range
240 days
+9.95%
5 years
+3.44%
Downside Risk-Adjusted Return
120 days
-30.85%
240 days
-30.85%
Maximum Daily Upside Volatility
60 days
+59.68%
Maximum Daily Downside Volatility
60 days
+55.60%
Liquidity
Average Turnover Rate
60 days
+16.63%
120 days
+16.67%
5 years
--
Turnover Deviation
20 days
+71.67%
60 days
+115.06%
120 days
+115.49%
Peer Comparison
Healthcare Providers & Services
Hims & Hers Health Inc
HIMS
6.85 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.79 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
ALHC
8.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pennant Group Inc
PNTG
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Sotera Health Co
SHC
8.29 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
US Physical Therapy Inc
USPH
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Hims & Hers Health Inc?
The TradingKey Stock Score provides a comprehensive assessment of Hims & Hers Health Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Hims & Hers Health Inc’s performance and outlook.
How do we generate the financial health score of Hims & Hers Health Inc?
To generate the financial health score of Hims & Hers Health Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Hims & Hers Health Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Hims & Hers Health Inc.
How do we generate the company valuation score of Hims & Hers Health Inc?
To generate the company valuation score of Hims & Hers Health Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Hims & Hers Health Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Hims & Hers Health Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Hims & Hers Health Inc.
How do we generate the earnings forecast score of Hims & Hers Health Inc?
To calculate the earnings forecast score of Hims & Hers Health Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Hims & Hers Health Inc’s future.
How do we generate the price momentum score of Hims & Hers Health Inc?
When generating the price momentum score for Hims & Hers Health Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Hims & Hers Health Inc’s prices. A higher score indicates a more stable short-term price trend for Hims & Hers Health Inc.
How do we generate the institutional confidence score of Hims & Hers Health Inc?
To generate the institutional confidence score of Hims & Hers Health Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Hims & Hers Health Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Hims & Hers Health Inc.
How do we generate the risk management score of Hims & Hers Health Inc?
To assess the risk management score of Hims & Hers Health Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Hims & Hers Health Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Hims & Hers Health Inc.
